Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ad P Ijzerman

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
European Journal of Pharmacology|December 4, 2003
Cyclopentyladenosine and some of its low-efficacy derivatives inhibit striatal synaptosomal release of acetylcholine to a similar degreeTjerk J H Bueters, Leonie M van Duivenvoorde, Meindert Danhof, et al.
Journal of Medicinal Chemistry|July 26, 2002
Pyrido[2,1-f]purine-2,4-dione derivatives as a novel class of highly potent human A(3) adenosine receptor antagonistsEva-María Priego, Jacobien von Frijtag Drabbe Kuenzel, Ad P IJzerman, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2003
Adenosine A1 receptor agonist N6-cyclopentyladenosine affects the inactivation of acetylcholinesterase in blood and brain by sarinTjerk J H Bueters, Marloes J A Joosen, Herman P M van Helden, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2006
ZM241385, DPCPX, MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptorQilan Li, Kai Ye, Clara C Blad, et al.
Purinergic Signalling|December 5, 2016
A covalent antagonist for the human adenosine A<sub>2A</sub> receptorXue Yang, Guo Dong, Thomas J M Michiels, et al.
European Journal of Pharmacology|September 15, 2004
Allosteric modulation and constitutive activity of fusion proteins between the adenosine A1 receptor and different 351Cys-mutated Gi alpha-subunitsElisabeth Klaasse, Rianne A F de Ligt, Sophie F Roerink, et al.
Cellular Signalling|September 1, 2015
The adhesion G protein-coupled receptor G2 (ADGRG2/GPR64) constitutively activates SRE and NFκB and is involved in cell adhesion and migrationMiriam C Peeters, Michiel Fokkelman, Bob Boogaard, et al.
European Journal of Pharmacology|October 11, 2005
Allosteric modulators affect the internalization of human adenosine A1 receptorsElisabeth C Klaasse, Gijs van den Hout, Sophie F Roerink, et al.
Journal of Medicinal Chemistry|July 9, 2004
New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosineMargot W Beukers, Lisa C W Chang, Jacobien K von Frijtag Drabbe Künzel, et al.
Drug Development Research|January 19, 2024
Adenosine A<sub>1</sub> Receptor and Ligand Molecular ModelingMark W Dudley, Norton P Peet, David A Demeter, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
European Journal of Pharmacology|December 4, 2003
Cyclopentyladenosine and some of its low-efficacy derivatives inhibit striatal synaptosomal release of acetylcholine to a similar degreeTjerk J H Bueters, Leonie M van Duivenvoorde, Meindert Danhof, et al.
Journal of Medicinal Chemistry|July 26, 2002
Pyrido[2,1-f]purine-2,4-dione derivatives as a novel class of highly potent human A(3) adenosine receptor antagonistsEva-María Priego, Jacobien von Frijtag Drabbe Kuenzel, Ad P IJzerman, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2003
Adenosine A1 receptor agonist N6-cyclopentyladenosine affects the inactivation of acetylcholinesterase in blood and brain by sarinTjerk J H Bueters, Marloes J A Joosen, Herman P M van Helden, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2006
ZM241385, DPCPX, MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptorQilan Li, Kai Ye, Clara C Blad, et al.
Purinergic Signalling|December 5, 2016
A covalent antagonist for the human adenosine A<sub>2A</sub> receptorXue Yang, Guo Dong, Thomas J M Michiels, et al.
European Journal of Pharmacology|September 15, 2004
Allosteric modulation and constitutive activity of fusion proteins between the adenosine A1 receptor and different 351Cys-mutated Gi alpha-subunitsElisabeth Klaasse, Rianne A F de Ligt, Sophie F Roerink, et al.
Cellular Signalling|September 1, 2015
The adhesion G protein-coupled receptor G2 (ADGRG2/GPR64) constitutively activates SRE and NFκB and is involved in cell adhesion and migrationMiriam C Peeters, Michiel Fokkelman, Bob Boogaard, et al.
European Journal of Pharmacology|October 11, 2005
Allosteric modulators affect the internalization of human adenosine A1 receptorsElisabeth C Klaasse, Gijs van den Hout, Sophie F Roerink, et al.
Journal of Medicinal Chemistry|July 9, 2004
New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosineMargot W Beukers, Lisa C W Chang, Jacobien K von Frijtag Drabbe Künzel, et al.
Drug Development Research|January 19, 2024
Adenosine A<sub>1</sub> Receptor and Ligand Molecular ModelingMark W Dudley, Norton P Peet, David A Demeter, et al.
Pageof 6